New analysis of data from longitudinal cohorts finds that psoriatic arthritis patients were more than 50% more likely than those with psoriasis but no arthritis to develop infection. It also provides further evidence that biologic medications are also a risk factor for infection.
The European Commission has approved expanded use of a Bristol-Myers Squibb hepatitis C drug to include patient populations with decompensated cirrhosis, HIV-1 coinfection and post-liver transplant recurrence of the virus.
It was only yesterday that the World Health Organization (WHO) declared that the Zika virus is an international public health emergency. Sanofi Pasteur, the vaccine division of Sanofi, announced today that it has launched a vaccine development effort.
The Centers for Disease Control and Prevention (CDC) is urging dialysis providers to assess and improve infection control practices, in part because the agency has received an increased number of reports of newly acquired HCV infection among patients undergoing hemodialysis.